Singapore markets open in 1 hour

Straits Times Index
3,110.73
+36.47(+1.19%)
S&P 500
4,604.37
+18.78(+0.41%)
Dow
36,247.87
+130.47(+0.36%)
Nasdaq
14,403.97
+63.97(+0.45%)
Bitcoin USD
43,779.70
+53.71(+0.12%)
CMC Crypto 200
914.81
+18.10(+2.02%)

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

9.62

+0.03

(+0.31%)

At close: 04:00PM EST

9.61

-0.01

(-0.10%)

After hours:

07:18PM EST

Trade prices are not sourced from all markets

Press Releases

Business Wire
Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
SAN FRANCISCO, December 06, 2023--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Vir’s Chief Executive Officer, will present at the J.P. Morgan 2024 42nd Annual Healthcare Conference on Wednesday, January 10, at 3:45 p.m. PT / 6:45 p.m. ET.
Business Wire
Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
SAN FRANCISCO, November 13, 2023--Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
Business Wire
Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023
SAN FRANCISCO, November 10, 2023--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that it will be presenting new data from its Phase 2 trials evaluating the potential clinical impact that VIR-3434 and VIR-2218 could have for chronic hepatitis B (CHB) and chronic hepatitis delta (CHD) patients at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting®, taking place in Boston, MA, from November 10-14, 2023. These include one late-breaking poster presentation and o